OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
April 01, 2013
First gene therapy and plant-based expression vector products approved in 2012.
The author outlines the need for custom-cell products.
Benchmarking can be a useful tool to improve manufacturing practices.
An innovative approach to capacity management.
Have FDA initiatives improved manufacturing quality?
Latin America's diverse growing market seeks regulatory harmonization.
The authors propose a roadmap for analytical lifecycle development.
Opioid abuse generates calls for efforts to curb distribution.
Sound policies are needed to govern the substitution of interchangeable biologics.
Early-stage companies are finding alternatives to venture capital.
Applications of ZFN technology in biopharmaceutical cell-line engineering.
Ontario-area scientists discuss approaches to development of stem-cell therapies.
EU authorities are stepping up their efforts to incorporate QbD principles.
The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.
The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.
Click the title above to open the BioPharm International April 2013 issue in an interactive PDF format.